SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Mark Catalano who wrote (7696)1/4/1998 11:27:00 PM
From: DMore  Respond to of 14328
 
I can see $6 or more this year. We saw $7 before without
near the fundamentals, products, etc. that we now have.
A 30-40 PE is not out of the question for a growth
company and if TRIBY does .15-.25, then $6+ is a very
possible target. Not to mention FDA approval on the HIV
test and this stock could get crazy. A little overreaction
to the upside would be extremely nice considering what
we have been unjustly seen on the downside.
DMore (DMerrier)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News